CORAL LABORATORIES LTD. Share Price

CORAL LABORATORIES LTD. Share Price

BSE: 524506
|
Pharmaceuticals
|
S Cap
₹ 598.00
+₹17.25 (2.97%)
1D
Last updated 23 Sep, 2026, 14:38 IST

CORAL LABORATORIES LTD. Share Price Today

As of 23 Sep 2026, CORAL LABORATORIES LTD. share price is ₹598.00. The stock opened at ₹598.00, compared to its previous close of ₹580.75. During today's trading session, CORAL LABORATORIES LTD. share price moved in the range of ₹576.05 to ₹598.00, with an average price of ₹587.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹360.00 and a high of ₹679.00.

₹576.05
2.97% up today
₹598.00
1D LOW
1D HIGH

CORAL LABORATORIES LTD. Returns Calculator

Circuit
L
H
₹551.75
₹609.75
52-week
L
H
₹360.00
₹679.00

About CORAL LABORATORIES LTD.

CORAL LABORATORIES LTD. Share Price
ISIN
INE683E01017
Sector Market Cap
₹ 207.33 Cr

Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.

CORAL LABORATORIES LTD. Financial Highlights

  • Revenue: CORAL LABORATORIES LTD. reported revenue of ₹95.80 crore in FY26 vs ₹124.12 crore in FY25. It showed a decrease of 22.82% on a yearly basis.
  • Operating Profit: CORAL LABORATORIES LTD. reported an operating profit of ₹23.12 crore in FY26 vs ₹32.47 crore in FY25. It showed a decrease of 28.80% on a year-on-year basis.
  • Net Profit: CORAL LABORATORIES LTD. reported a net profit of ₹16.38 crore in FY26 vs ₹24.16 crore in FY25. It showed a decrease of 32.20% on a yearly basis.

CORAL LABORATORIES LTD. Quarterly Result Highlights

  • CORAL LABORATORIES LTD. reported revenue of ₹31.77 crore in Jun 2026, compared with ₹29.13 crore in Mar 2026, representing an increase of 9.06% on a quarter-on-quarter (QoQ) basis.
  • CORAL LABORATORIES LTD. reported an operating profit of ₹6.94 crore in Jun 2026, compared with ₹8.29 crore in Mar 2026, representing a decrease of 16.28% on a quarter-on-quarter (QoQ) basis.
  • CORAL LABORATORIES LTD. reported a profit of ₹5.39 crore in Jun 2026, compared with ₹5.22 crore in Mar 2026, reflecting an increase of 3.26% on a QoQ basis.
  • The earnings per share (EPS) of CORAL LABORATORIES LTD. stood at ₹45.85 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
71.51%
FII
0.00%
Other DII
0.00%
Retail and other
28.49%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
207.33
P/E
10.79
P/B
0.99
ROE
7.83%
D/E
0.02
ROCE
10.89%
Div. Yield
0.34%
EPS(TTM)
45.85
Turnover
0.40
EV/EBITDA
4.76
Net Margin
19.07%
Op. Margin
29.59%
ROA
7.98%
Quick Ratio
0.00
Curr. Ratio
7.70
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Coral Labs. has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Coral Labs. appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

CORAL LABORATORIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹85.90₹115.01₹83.66₹78.12
Other Income₹9.90₹9.11₹6.63₹6.90
Total Revenue₹95.80₹124.11₹90.29₹85.01
Total Expenses₹72.99₹90.87₹69.40₹76.83
Profit Before Tax₹23.11₹32.47₹20.73₹8.23
Tax₹6.73₹8.31₹4.94₹1.78
Profit After Tax₹16.38₹24.16₹15.79₹6.45
EPS - Basic₹45.85₹67.61₹44.19₹18.04
EPS - Diluted₹45.85₹67.61₹44.19₹18.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹33.24₹20.90₹8.19₹10.90
Income before WC changes₹30.23₹18.93₹8.57₹10.89
Change in Assets-₹17.23-₹25.02₹13.35-₹3.37
Change in Liabilities-₹6.89₹5.51-₹7.29₹2.93
Change in WC-₹24.12-₹19.51₹6.06-₹0.44
Cash flow from Operations-₹1.22-₹5.46₹12.67₹6.08
Cash flow from Investing-₹0.15₹1.40-₹2.61-₹6.05
Cash flow from Financing₹2.71₹0.01-₹6.43₹0.15
Total Cash Flow₹1.33-₹4.06₹3.62₹0.18
Cash (Start of the year)₹2.07₹6.13₹2.51₹2.32
Cash (End of the year)₹3.41₹2.07₹6.13₹2.51

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹63.70₹52.92₹51.83₹50.81
Current Assets₹176.97₹176.55₹153.85₹123.54
Total Assets₹240.66₹229.46₹205.68₹174.35
Current Liabilities₹27.31₹24.96₹24.90₹11.86
Net Current Asset₹149.66₹151.59₹128.96₹111.68
Non-Current Liabilities₹4.24₹3.30₹3.28₹7.69
Equity Capital₹209.11₹201.21₹177.50₹154.80
Total Equity & Liabilities₹240.66₹229.46₹205.68₹174.35
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
597
5
597.9
7
598
50
0
0
0
0
Bid Total: 0
Ask Total: 62
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
5
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
47.66
Neutral
ATR (14)
28.68
Neutral
STOCH(9,6)
48.06
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
20.87
Bearish
UO(9)
41.3
Neutral
ROC(12)
-0.73
Bearish
WillR(14)
-58.41
Neutral
Period
Simple value
Exponential vaue
5D
575.19
576.25
10D
573.83
578.15
20D
592.07
585.12
50D
591.76
582.55
100D
552.13
554.92
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
CORAL LABORATORIES LTD. Share Price
CORAL LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

CORAL LABORATORIES LTD. Share Price FAQs

CORAL LABORATORIES LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837